Eton Pharmaceuticals (ETON) News Today $17.04 +0.34 (+2.04%) Closing price 04:00 PM EasternExtended Trading$17.02 -0.02 (-0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETON Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Bought by Connor Clark & Lunn Investment Management Ltd.August 15 at 4:28 AM | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Sold by Informed Momentum Co LLCAugust 14 at 5:48 AM | marketbeat.comEton Pharmaceuticals Reports Strong Q2 Growth Amid ChallengesAugust 13 at 4:31 AM | msn.comEton Pharmaceuticals (NASDAQ:ETON) Cut to Hold at Wall Street ZenAugust 12 at 2:11 AM | americanbankingnews.comWall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to HoldAugust 10, 2025 | marketbeat.comEton targets $80M revenue run-rate in Q3 2025 as product launches accelerateAugust 8, 2025 | msn.comEton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comEton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With OptionsAugust 8, 2025 | seekingalpha.comEton Pharmaceuticals Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comEton Pharmaceuticals (ETON) to Release Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comNeurocrine Biosciences Positioned For Growth And New Potential BlockbustersJuly 31, 2025 | seekingalpha.comEton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025July 28, 2025 | globenewswire.comB. Riley Analysts Lift Earnings Estimates for ETONJuly 21, 2025 | marketbeat.comB. Riley Research Analysts Raise Earnings Estimates for ETONJuly 18, 2025 | marketbeat.comAdrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and PfizerJuly 11, 2025 | finance.yahoo.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) - Seeking AlphaJuly 9, 2025 | seekingalpha.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) - MorningstarJuly 9, 2025 | morningstar.comMEton Pharmaceuticals Announces FDA Acceptance of NDA for ET-600 with Target Action Date of February 25, 2026 - NasdaqJuly 9, 2025 | nasdaq.comEton Pharmaceuticals Inc Sustainability - MorningstarJuly 9, 2025 | morningstar.comMEton Pharmaceuticals Shares Rise Premarket as FDA to Review ET-600July 8, 2025 | marketwatch.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)July 8, 2025 | globenewswire.comEton Pharmaceuticals Inc. Annual Income Statement - MarketWatchJuly 2, 2025 | marketwatch.comWestside Investment Management Inc. Sells 81,572 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON)June 30, 2025 | marketbeat.comEton Pharmaceuticals to join Russell indexesJune 27, 2025 | msn.comEton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® IndexesJune 27, 2025 | finance.yahoo.comEton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® IndexesJune 27, 2025 | globenewswire.comEton Pharmaceuticals IncJune 20, 2025 | morningstar.comMInsiders Back These 3 High Growth CompaniesJune 17, 2025 | finance.yahoo.comDavid Krempa Sells 6,800 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) StockJune 17, 2025 | insidertrades.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Growth in Short InterestJune 16, 2025 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Insider David Krempa Sells 6,800 SharesJune 16, 2025 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Insider David Krempa Sells 10,223 SharesJune 16, 2025 | marketbeat.comDavid Krempa Sells 16,977 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) StockJune 16, 2025 | marketbeat.comB. Riley Forecasts Higher Earnings for Eton PharmaceuticalsJune 9, 2025 | marketbeat.comEton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More UpsideJune 6, 2025 | seekingalpha.comB. Riley Raises Earnings Estimates for Eton PharmaceuticalsJune 6, 2025 | marketbeat.comGLP-1 Nutrition Guidelines; Oral Hydrocortisone OK'd; Vegan Diet for Hot Flashes?June 4, 2025 | msn.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Sees Large Decrease in Short InterestJune 4, 2025 | marketbeat.comTwo Sigma Advisers LP Invests $662,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)June 4, 2025 | marketbeat.comTwo Sigma Investments LP Invests $1.50 Million in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)June 4, 2025 | marketbeat.comMillennium Management LLC Acquires New Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON)June 3, 2025 | marketbeat.comHC Wainwright Issues Optimistic Estimate for ETON EarningsMay 31, 2025 | marketbeat.comFDA approves Eton’s application for hydrocortisone oral solutionMay 30, 2025 | msn.comEton Pharmaceuticals (NASDAQ:ETON) Shares Gap Up - Here's WhyMay 30, 2025 | marketbeat.comEton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI (hydrocortisone) Oral SolutionMay 30, 2025 | finanznachrichten.deNorthern Trust Corp Purchases 22,827 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON)May 30, 2025 | marketbeat.comEton Pharmaceuticals stock rises on FDA approval of KHINDIVIMay 29, 2025 | investing.comEton Pharmaceuticals Gains on FDA Green Light for Pediatric Drug KHINDIVIMay 29, 2025 | msn.comEton Pharma wins FDA nod for oral hydrocortisone solutionMay 29, 2025 | msn.comFDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 RevenueMay 29, 2025 | benzinga.com Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address ETON Media Mentions By Week ETON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼0.640.61▲Average Medical News Sentiment ETON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼84▲ETON Articles Average Week Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VCEL News BEAM News SRPT News ARQT News ANIP News SPRY News APGE News IMCR News DYN News CDTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access